Corindus Vascular Robotics (OTC:CVRS), a Massachusetts-based surgical robotics company, plans to utilize technology that creates 3D images of arteries for evaluating patients.
Company officials said they’d employ California-based HeartFlow’s FFRct Analysis in a case series of robotic-assisted percutaneous coronary interventions to evaluate the technology’s role in clinical decision support. The testing will be done at hospitals in Michigan and Texas, according to an Oct. 23 news release.
Get the full story at our sister site, The Robot Report.
The post Corindus Vascular Robotics to test-drive HeartFlow’s 3D cardiac imaging tech appeared first on MassDevice.
from MassDevice http://ift.tt/2iwP9k2
Cap comentari:
Publica un comentari a l'entrada